Primera página del artículo de sobre bronquiectasias. THEODORE WILLIAMS, C. la fisiopatología de las bronquiectasias. El conocimiento acerca de. RESUMO: As bronquiectasias, outrora frequentes, têm vindo a tomarse numa situação patológia comparativamente rara. No entanto, a sua importância clínica . Las bronquiectasias no asociadas a fibrosis quística son una enfermedad compleja que ha despertado cada vez más interés científico debido a su creciente.
|Published (Last):||2 June 2010|
|PDF File Size:||7.55 Mb|
|ePub File Size:||8.67 Mb|
|Price:||Free* [*Free Regsitration Required]|
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. British Thoracic Society guideline for non-CF bronchiectasis. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: Ann Am Thorac Soc.
Monografías de Archivos de Bronconeumología
The bronchiectasis severity index. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Microbiologic follow-up study in adult bronchiectasis. Kellett F, Robert NM. Exacerbations in cystic fibrosis: Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with noncystic fibrosis bronchiectasis.
Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. British Thoracic Society Research Committee. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I.
Bilateral bronchiectasis and bronchiolitis at thin-section CT: Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis.
Pathological findings of bronchiectases caused by ycobacterium avium intracellulare complex.
There was a problem providing the content you requested
Goyal V, Chang AB. An international derivation and validation study. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis.
Multidimensional approach to non-cystic fibrosis bronchiectasis: A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Cochrane Database Syst Rev. State of the art review: Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Mortality in non-cystic fibrosis bronchiectasis: Chest physiotherapy techniques in bronchiectasis.
Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis. Polymicrobial airway bacterial communities in adult bronchiectasis patients. Trace Ce and Host Defense: A prospective cohort analysis.
Bronchiectasis-associated hospitalizations in Germany, Inhaled steroids for bronchiectasis. Inhaled hyperosmolar agents for bronchiectasis. Recent Advances and Continuing Challenges.
Bronquiectasias | Blausen Medical
A novel microbiota stratification system predicts future exacerbations in bronchiectasis. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Servicio de ayuda de la revista.
Chang AB, Bilton D. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of dw symptoms. Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis.
Bronchiectasis in a diverse US population. Controlled trial of ceftazidime vs. Lax short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised controlled trial. Systemic comorbidities in bronchiectasis.